SPATA4
gene geneOn this page
Also known as TSARG2SPEF1BFAP178CFAP178
Summary
SPATA4 (spermatogenesis associated 4, HGNC:17333) is a protein-coding gene on chromosome 4q34.2, encoding Spermatogenesis-associated protein 4 (Q8NEY3). May play a role in apoptosis regulation.
Predicted to enable microtubule binding activity. Predicted to be involved in regulation of cytoskeleton organization. Located in cytosol and nucleoplasm.
Source: NCBI Gene 132851 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 54 total
- MANE Select transcript:
NM_144644
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17333 |
| Approved symbol | SPATA4 |
| Name | spermatogenesis associated 4 |
| Location | 4q34.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TSARG2, SPEF1B, FAP178, CFAP178 |
| Ensembl gene | ENSG00000150628 |
| Ensembl biotype | protein_coding |
| OMIM | 609879 |
| Entrez | 132851 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay
ENST00000280191, ENST00000508699, ENST00000515234
RefSeq mRNA: 1 — MANE Select: NM_144644
NM_144644
CCDS: CCDS3826
Canonical transcript exons
ENST00000280191 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000995660 | 176188119 | 176188235 |
| ENSE00001130718 | 176193453 | 176193582 |
| ENSE00001254627 | 176184579 | 176184892 |
| ENSE00001254631 | 176195345 | 176195585 |
| ENSE00003578066 | 176192627 | 176192847 |
| ENSE00003581422 | 176192958 | 176193076 |
Expression profiles
Bgee: expression breadth ubiquitous, 151 present calls, max score 96.95.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6854 / max 322.9768, expressed in 122 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 55023 | 0.5940 | 101 |
| 55026 | 0.0450 | 7 |
| 55025 | 0.0244 | 3 |
| 55024 | 0.0219 | 3 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 96.95 | gold quality |
| left testis | UBERON:0004533 | 96.93 | gold quality |
| right testis | UBERON:0004534 | 96.45 | gold quality |
| adult organism | UBERON:0007023 | 96.15 | gold quality |
| testis | UBERON:0000473 | 94.31 | gold quality |
| bronchial epithelial cell | CL:0002328 | 91.31 | gold quality |
| bronchus | UBERON:0002185 | 89.05 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.91 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.24 | gold quality |
| right uterine tube | UBERON:0001302 | 83.33 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 81.09 | gold quality |
| tibialis anterior | UBERON:0001385 | 77.25 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 76.73 | silver quality |
| fallopian tube | UBERON:0003889 | 64.98 | gold quality |
| oviduct epithelium | UBERON:0004804 | 63.64 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 63.19 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 62.93 | gold quality |
| deltoid | UBERON:0001476 | 61.16 | gold quality |
| islet of Langerhans | UBERON:0000006 | 61.02 | gold quality |
| prefrontal cortex | UBERON:0000451 | 60.07 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 59.89 | gold quality |
| muscle of leg | UBERON:0001383 | 59.70 | gold quality |
| right lung | UBERON:0002167 | 59.70 | gold quality |
| hypothalamus | UBERON:0001898 | 59.59 | gold quality |
| pancreatic ductal cell | CL:0002079 | 59.50 | silver quality |
| nucleus accumbens | UBERON:0001882 | 59.27 | gold quality |
| adenohypophysis | UBERON:0002196 | 59.02 | gold quality |
| gastrocnemius | UBERON:0001388 | 58.96 | gold quality |
| pituitary gland | UBERON:0000007 | 58.59 | gold quality |
| calcaneal tendon | UBERON:0003701 | 58.52 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.27 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): RFX1
miRNA regulators (miRDB)
20 targeting SPATA4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-4677-5P | 99.70 | 70.09 | 1940 |
| HSA-MIR-302B-5P | 99.50 | 69.49 | 1857 |
| HSA-MIR-302D-5P | 99.50 | 69.34 | 1863 |
| HSA-MIR-323B-3P | 99.14 | 68.89 | 725 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-4433B-3P | 97.22 | 63.62 | 663 |
| HSA-MIR-3116 | 97.07 | 65.78 | 1324 |
| HSA-MIR-4790-3P | 96.63 | 67.08 | 806 |
| HSA-MIR-6777-3P | 95.35 | 64.30 | 699 |
| HSA-MIR-8074 | 90.61 | 65.46 | 165 |
Literature-anchored findings (GeneRIF, showing 7)
- expressed in many tissues and mapped to chromosome 4q33-34.1 by database analyses (PMID:12019456)
- TSARG2 may play an important role in the development of cryptorchid testis and be a testis-specific apoptosis candidate oncogene (PMID:15158438)
- analysis of SPATA4 expression and variation in promotor sequences (PMID:16336790)
- Results suggest a role for SPATA4 in membrane traffic and a specialized function for TRAPP in spermatocytes. (PMID:21827752)
- SPATA4 protects HeLa cells against etoposide-induced apoptosis through the mitochondrial apoptotic pathway, providing further evidence that SPATA4 plays a role in regulating apoptosis (PMID:26424010)
- Increased DNA methylation in the spermatogenesis-associated (SPATA) genes correlates with infertility. (PMID:31838782)
- SPATA4 improves aging-induced metabolic dysfunction through promotion of preadipocyte differentiation and adipose tissue expansion. (PMID:33314576)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spata4 | ENSDARG00000036189 |
| mus_musculus | Spata4 | ENSMUSG00000031518 |
| rattus_norvegicus | Spata4 | ENSRNOG00000048035 |
Paralogs (1): SPEF1 (ENSG00000101222)
Protein
Protein identifiers
Spermatogenesis-associated protein 4 — Q8NEY3 (reviewed: Q8NEY3)
Alternative names: Testis and spermatogenesis cell-related protein 2, Testis spermatocyte apoptosis-related gene 2 protein
All UniProt accessions (3): Q8NEY3, G5E9Y6, H0YA30
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in apoptosis regulation.
Subunit / interactions. Interacts with CFAP65.
Subcellular location. Nucleus.
Tissue specificity. Highly expressed in testis, the expression is observed precisely in seminiferous tubules.
RefSeq proteins (1): NP_653245* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001715 | CH_dom | Domain |
| IPR010441 | CH_2 | Domain |
| IPR036872 | CH_dom_sf | Homologous_superfamily |
| IPR052111 | Spermatogenesis_Ciliary_MAP | Family |
Pfam: PF06294
UniProt features (4 total): chain 1, domain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NEY3-F1 | 75.66 | 0.46 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 52 (showing top):
chr4q34, GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION, GOCC_CYTOPLASMIC_REGION, GOCC_CILIUM, WEBER_METHYLATED_HCP_IN_SPERM_DN, GOMF_CYTOSKELETAL_PROTEIN_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP, FOXN3_TARGET_GENES, HMGA1_TARGET_GENES, ID1_TARGET_GENES, IRF5_TARGET_GENES, SKIL_TARGET_GENES, SNRNP70_TARGET_GENES, ZNF597_TARGET_GENES
GO Biological Process (1): regulation of cytoskeleton organization (GO:0051493)
GO Molecular Function (2): microtubule binding (GO:0008017), protein binding (GO:0005515)
GO Cellular Component (5): nucleoplasm (GO:0005654), cytosol (GO:0005829), axoneme (GO:0005930), nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cytoskeleton organization | 1 |
| regulation of organelle organization | 1 |
| tubulin binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
1083 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA4 | SPATA17 | Q96L03 | 694 |
| SPATA4 | PLAAT5 | Q96KN8 | 543 |
| SPATA4 | SPATA20 | Q8TB22 | 532 |
| SPATA4 | ELMOD2 | Q8IZ81 | 531 |
| SPATA4 | ASB5 | Q8WWX0 | 520 |
| SPATA4 | SPATA22 | Q8NHS9 | 496 |
| SPATA4 | MTUS1 | Q9ULD2 | 491 |
| SPATA4 | SPATA6 | Q9NWH7 | 491 |
| SPATA4 | WDR17 | Q8IZU2 | 489 |
| SPATA4 | KLHDC3 | Q9BQ90 | 471 |
| SPATA4 | FANK1 | Q8TC84 | 466 |
| SPATA4 | GGNBP2 | Q9H3C7 | 465 |
| SPATA4 | SPAG17 | Q6Q759 | 463 |
| SPATA4 | PMFBP1 | Q8TBY8 | 457 |
| SPATA4 | ZCCHC3 | Q9NUD5 | 457 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SIAH1 | SPATA4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATA4 | FAT3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SPATA4 | LCN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Trappc2 | SPATA4 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (7): SPATA4 (Two-hybrid), SPATA4 (Reconstituted Complex), SPATA4 (Biochemical Activity), FAT3 (Affinity Capture-MS), LCN1 (Affinity Capture-MS), APP (Reconstituted Complex), SPATA4 (Two-hybrid)
ESM2 similar proteins: A0A1L8HBI7, A0A1L8HJK9, A0A1L8HTT5, A6NP61, A7E2V4, B2RVL6, C0SPG1, C3VD30, K7SGN7, P56163, P56198, P62932, Q1XFL1, Q29RJ0, Q32L09, Q3UHH1, Q3V0J4, Q497M3, Q4R739, Q58D79, Q5EA86, Q5R8D5, Q5TKR9, Q5VWQ0, Q5XI33, Q6DMN8, Q768S4, Q7T3T8, Q7T3T9, Q7T3U0, Q80T69, Q8BV79, Q8BZ21, Q8CAK3, Q8CDN1, Q8HXK7, Q8K3Y6, Q8N2G6, Q8N9V6, Q8ND61
Diamond homologs: Q0IH24, Q58DA1, Q6DMN8, Q8K3V1, Q8NEY3, Q99JL1, Q9Y4P9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
935 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:176188112:AACTT:A | donor_loss | 1.0000 |
| 4:176188113:ACT:A | donor_loss | 1.0000 |
| 4:176188114:CTTAC:C | donor_loss | 1.0000 |
| 4:176188115:T:TA | donor_loss | 1.0000 |
| 4:176188116:TACGT:T | donor_loss | 1.0000 |
| 4:176188117:A:AC | donor_gain | 1.0000 |
| 4:176188117:A:T | donor_loss | 1.0000 |
| 4:176188118:C:CC | donor_gain | 1.0000 |
| 4:176188138:T:TA | donor_gain | 1.0000 |
| 4:176188231:CCATT:C | acceptor_gain | 1.0000 |
| 4:176188232:CATT:C | acceptor_gain | 1.0000 |
| 4:176188232:CATTC:C | acceptor_gain | 1.0000 |
| 4:176188233:ATT:A | acceptor_gain | 1.0000 |
| 4:176188233:ATTC:A | acceptor_loss | 1.0000 |
| 4:176188234:TT:T | acceptor_gain | 1.0000 |
| 4:176188235:TC:T | acceptor_loss | 1.0000 |
| 4:176188236:C:A | acceptor_loss | 1.0000 |
| 4:176188236:C:CC | acceptor_gain | 1.0000 |
| 4:176192846:TT:T | acceptor_gain | 1.0000 |
| 4:176192846:TTC:T | acceptor_loss | 1.0000 |
| 4:176192848:C:CC | acceptor_gain | 1.0000 |
| 4:176192848:CT:C | acceptor_loss | 1.0000 |
| 4:176192849:T:A | acceptor_loss | 1.0000 |
| 4:176192956:A:AC | donor_gain | 1.0000 |
| 4:176192957:C:CC | donor_gain | 1.0000 |
| 4:176192957:CT:C | donor_gain | 1.0000 |
| 4:176192957:CTCT:C | donor_gain | 1.0000 |
| 4:176193594:CAAT:C | acceptor_gain | 1.0000 |
| 4:176193595:A:T | acceptor_gain | 1.0000 |
| 4:176193597:T:C | acceptor_gain | 1.0000 |
AlphaMissense
1981 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:176193470:A:G | W111R | 0.995 |
| 4:176193470:A:T | W111R | 0.995 |
| 4:176193468:C:A | W111C | 0.993 |
| 4:176193468:C:G | W111C | 0.993 |
| 4:176193568:C:T | G78D | 0.992 |
| 4:176195391:A:G | W58R | 0.989 |
| 4:176195391:A:T | W58R | 0.989 |
| 4:176193480:C:A | K107N | 0.987 |
| 4:176193480:C:G | K107N | 0.987 |
| 4:176193569:C:G | G78R | 0.987 |
| 4:176193570:A:C | N77K | 0.986 |
| 4:176193570:A:T | N77K | 0.986 |
| 4:176193469:C:G | W111S | 0.985 |
| 4:176193568:C:A | G78V | 0.985 |
| 4:176193014:T:A | K137N | 0.984 |
| 4:176193014:T:G | K137N | 0.984 |
| 4:176193471:G:C | N110K | 0.984 |
| 4:176193471:G:T | N110K | 0.984 |
| 4:176193582:T:A | R73S | 0.982 |
| 4:176193582:T:G | R73S | 0.982 |
| 4:176193556:G:T | A82E | 0.980 |
| 4:176195387:A:G | L59P | 0.978 |
| 4:176193027:G:T | T133K | 0.977 |
| 4:176188228:A:C | F232L | 0.976 |
| 4:176188228:A:T | F232L | 0.976 |
| 4:176188230:A:G | F232L | 0.976 |
| 4:176193557:C:G | A82P | 0.974 |
| 4:176193577:A:G | F75S | 0.973 |
| 4:176193482:T:C | K107E | 0.972 |
| 4:176195389:C:A | W58C | 0.971 |
dbSNP variants (sampled 300 via entrez): RS10000168 (4:176189051 G>A), RS1000136954 (4:176190108 C>A,T), RS1000145716 (4:176194759 G>C,T), RS10004325 (4:176185138 G>A,C), RS1000495002 (4:176185055 T>G), RS1000684887 (4:176191548 G>A), RS1000740853 (4:176188795 T>C), RS1001089723 (4:176188553 T>G), RS1001861282 (4:176191101 T>A,G), RS1001892351 (4:176191292 C>T), RS1001930311 (4:176197233 G>A), RS1002086723 (4:176194527 G>C), RS1002429877 (4:176196998 A>G), RS10027520 (4:176185323 C>T), RS1003008767 (4:176184722 C>A,G)
Disease associations
OMIM: gene MIM:609879 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Smoke | increases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.